Serum Sclerostin in Hepatitis C Virus Infected Patients

BACKGROUND: Sclerostin inhibits osteoblast functions, differentiations, and survival rates. As an endogenous inhibitor of the Wnt/β-catenin pathway, the sclerostin should be related to decreased bone masses, although several studies indicate opposite results. In addition, it may be related to insuli...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Reimers, Emilio, López-Prieto, Javier, Pelazas-González, Ricardo, Alemán-Valls, M.Remedios, José de la Vega-Prieto, María, Jorge-Ripper, Carlos, Durán-Castellón, M. Carmen, Santolaria-Fernández, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970296/
https://www.ncbi.nlm.nih.gov/pubmed/24707469
http://dx.doi.org/10.11005/jbm.2014.21.1.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970296/
https://www.ncbi.nlm.nih.gov/pubmed/24707469
http://dx.doi.org/10.11005/jbm.2014.21.1.69

Ejemplares similares